As of Aug 29
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Rxi Pharmaceuticals Corp have a median target of 35.00, with a high estimate of 35.00 and a low estimate of 35.00. The median estimate represents a +1,402.15% increase from the last price of 2.33.
The current consensus among 1 polled investment analysts is to Buy stock in Rxi Pharmaceuticals Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.